Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis

Journal of the American Society of Nephrology

Volumn 7, Issue 10, 1996, Pages 2044-2054

  De Lemos, James A ^a   Hillis, L David ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Coronary angiography; Coronary artery disease; Ischemic heart disease

Indexed keywords

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC APPROACH ROUTE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0030392343     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. United States Renal Data System. USRDS 1994 Annual Data Report. Bethesda, MD: National Institutes of Health; 1994.
2. Hellerstedt W, Johnson W, Ascher N, et al.: Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc 1984;59:776-783.
3. Wing A, Broyer M, Brunner F, et al.: Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc 1983;20:2-76.
4. Brunner F, Brynger H, Chantier C, et al.: Combined report on regular dialysis and transplantation in Europe, IX, 1978. Proc Eur Dial Transplant Assoc 1979;16:2-74.
5. US Bureau of the Census. Statistical Abstract of the United States: 1994 (114th edition). Washington, DC: 1994.
6. Lindner A, Charra B, Sherrard D, Scribner B: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
7. Ansari A, Kaupke C, Vaziri N, Miller R, Barbari A: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 1993;16:31-36.
8. Rostand S, Kirk K, Rutsky E: The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management. Contrib Nephrol 1986;52:34-41.
9. Weinrauch L, D'Elia J, Healy R, Gleason R, Christlieb R, Leland O: Asymptomatic coronary artery disease: Angiographic assessment of diabetics evaluated for renal transplantation. Circulation 1978;58:1184-1189.
10. Weinrauch L, D'Elia J, Healy R, et al.: Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Ann Intern Med 1978;88:346-348.
11. Bennett W, Kloster F, Rosch J, Barry J, Porter G: Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease. Am J Med 1978;65:779-784.
12. Rostand S, Gretes J, Kirk K, Rutsky E, Andreoli T: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 1979;16:600-611.
13. Nicholls A, Edward N, Catto G, Engeset J, Macleod M: Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: Fact or fiction? Lancet 1980; 1:276-278.
14. Burke J, Francos G, Moore L, Yon Cho S, Lasker N. Accelerated atherosclerosis in chronic dialysis patients - another look. Nephron 1978;21:181-185.
15. Ritz E, Wiecek A, Gnasso A, Augustin J: Is atherogenesis accelerated in uremia? Contrib Nephrol 1986;52: 1-9.
16. Braun W, Phillips D, Vidt D, et al.: Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984;16:603-607.
17. Krolewski A, Kosinski E, Warram J, et al.: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-755.
18. Manske C, Wilson R, Wang Y, Thomas W: Prevalence of, and risk factors for, angiographically determined coronary artery disease in type 1-diabetic patients with nephropathy. Arch Intern Med 1992;152:2450-2455.
19. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T: Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 1987;30:144-148.
20. Rostand S, Kirk K, Rutsky E: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 1982;22:304-308.
21. Bachmann J, Tepel M, Raidt H, et al.: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995;6:121-125.
22. Vincenti F, Amend W, Abele J, Feduska N, Salvatierra O: The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980;68:363-369.
23. Manske C: Coronary artery disease in diabetic patients with nephropathy. Am J Hypertens 1993;6[Suppl]: S367-S374.
24. Ambrose J, Tannenbaum M, Alexopoulos D, et al.: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
25. Little W, Constantinesco M, Applegate R, et al.: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-1166.
26. Goldberg I: Lipoprotein metabolism in normal and uremic patients. Am J Kidney Dis 1993;21:87-90.
27. Bagdade J: Uremic lipemia: An unrecognized abnormality in triglyceride production and removal. Arch Intern Med 1970;126:875-881.
28. Appel G: Lipid abnormalities in renal disease. Kidney Int 1991;39:169-183.
29. Drucke T, Lacour B, Roullet J, Funck-Brentand J: Recent advances in factors that alter lipid metabolism in chronic renal failure. Kidney Int 1983;24[Suppl]:S134-S138.
30. Rapoport J, Aviram M, Chaimovitz C, Brook J: Defective high-density lipoprotein composition in patients on chronic hemodialysis. N Engl J Med 1978;299:1326-1329.
31. Fuh M, Lee C, Jeng C, et al.: Effect of chronic renal failure on high-density lipoprotein kinetics. Kidney Int 1990;37:1295-1300.
32. Hahn R, Dette K, Mondorf H, Finke K, Sieberth H: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 1983;48:279-288.
33. Nestel P, Fidge N, Tan M: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 1982; 307:329-333.
34. Weintraub M, Burstein A, Rassin T, et al.: Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 1992;42:1247-1252.
35. Haffner S, Gruber K, Aldrete G, Morales P, Stern M, Tuttle K: Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol 1992;3:1156-1162.
36. Stampfer M, Malinow M, Willett W, et al.: A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. physicians. JAMA 1992;268:877-881.
37. Chaveau P, Chadefaux B, Coude M, et al.: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;43[Suppl 41]:S72-S77.
38. Hultberg B, Anderson A, Sterner G: Plasma homocysteine in renal failure. Clin Nephrol 1993;40:230-234.
39. Chaveau P, Chadefaux B, Coude M, et al.: Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab 1992;18: 196-198.
40. Philipson J, Carpenter B, Itzkoff J, et al.: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986;81:630-634.
41. Ramos E, Kasiske B, Alexander S, et al.: The evaluation of candidates for renal transplantation. Transplantation (Dallas) 1994;57:490-497.
42. Braun W, Phillips D, Vidt D, et al.: Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programs. Transplant Proc 1981;13: 128-135.
43. Brown K, Rimmer J, Haisch C: Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 1989;64:1017-1021.
44. Weinrauch L D'Elia J, Monaco A, et al.: Preoperative evaluation for diabetic renal transplantation: Impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med 1992;93:19-28.
45. Le A, Wilson R, Douek K, Pulliam L, et al.: Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994;24:65-71.
46. Manske C, Thomas W, Wang Y, Wilson R: Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993;44:617-621.
47. Camp A, Garvin P, Hoff J, Marsh J, Byers S, Chaitman B: Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990;65:1459-1463.
48. Reis G, Marcovitz P, Leichtman A, et al.: Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995;75:707-710.
49. Braun W, Marwick T: Coronary artery disease in renal transplant recipients. Cleve Clin J Med 1994;61:370-385.
50. Williams M: Management of the diabetic renal transplant recipient. Kidney Int 1995;48:1660-1674.
51. Morrow C, Schwartz J, Sutherland D, et al.: Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 1983;146:331-335.
52. Marwick TH, Steinmuller DR, Underwood DA, et al.: Ineffectiveness of dipyridamole spect thallium imaging as a screening technique for coronary artery disease in patients with end stage renal failure. Transplant 1990; 49:100-103.
53. Boudreau RJ, Strony JT, duCret RP, et al.: Perfusion thallium imaging of type I diabetes patients with end stage renal disease: Comparison of oral and intravenous dipyridamole administration. Radiol 1990;175:103-105.
54. Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R: Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 1991;36:192-202.
55. Kasiske B, Ramos E, Gaston R, et al.: The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995;6:1-34.
56. Smith M, Dunn M. Hypertension due to renal parenchymal disease. In: Brenner B, Rector F, Eds. The Kidney, 4th Ed. Philadelphia: W.B. Saunders Co.; 1991:1968-1996.
57. Rostand S, Rutsky E. Cardiac disease in dialysis patients. In: Nissenson A, Fine R, Gentile D, Eds. Clinical Dialysis, 2nd Ed. Norwalk, CT: Appelton & Lange; 1990: 409-446.
58. Acosta J: Hypertension in chronic renal disease. Kidney Int 1982;22:702-712.
59. Lindner A, Douglas S, Adamson J: Propranolol effects in long-term hemodialysis patients with renin-dependent hypertension. Ann Intern Med 1978;88:457-462.
60. Batlle D, von Riotte A, Lang G: Delayed hypotensive response to dialysis in hypertensive patients with end-stage renal disease. Am J Nephrol 1986;6:14-20.
61. Wizeman V, Kramer W: Choice of ESRD treatment strategy according to cardiac status. Kidney Int 1988; 24[Suppl]:S191-S195.
62. Hamazaki T, Nakazawa R, Tateno S, et al.: Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney Int 1984;26: 81-84.
63. Pasternack A, Vanttinen T, Solakivi T, Kuusi T, Korte T: Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure. Clin Nephrol 1987;27:163-168.
64. Kannel W, Castelli W, Gordon T, et al.: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 1971;74:1-12.
65. Pastan S, Braunwald E. Renal disorders and heart disease. In: Braunwald E, Ed. Heart Disease, 4th Ed. Philadelphia: W.B. Saunders Co.; 1992:1856-1874.
66. Wanner C, Wieland H, Schollmeyer P, Horl W: Effect of lovastatin on the lipoprotein system of hyperlipidemic hemodialysis patients [Abstract], Kidney Int 1990;37: 323A.
67. Shepherd J, Cobbe S, Ford I, et al.: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.
68. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-1389.
69. Kikeri D, Mitch W: The heart and kidney disease. In: Schlant R, Alexander R, Eds. Hurst's The Heart, 8th Ed. New York: McGraw Hill; 1994:1961-1970.
70. Livio M, Benigni A, Vigano G, Mecca G, Remuzzi G: Moderate doses of aspirin and risk of bleeding in renal failure. Lancet 1986;8478:414-416.
71. Glueck C, Shaw P, Lang J, et al.: Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995;75:132-136.
72. Wilcken D, Dudman N, Tyrrell P, Robertson M: Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease. Metab Clin Exp 1995;37:697-701.
73. Hillis LD: Coronary artery bypass surgery: Risks and benefits, realistic and unrealistic expectations. J Invest Med 1995;43:17-27.
74. Albert F, Seyfert U, Grossmann R, et al.: Role of coronary angiography and heart surgery in care of kidney transplant recipients. Transplant Proc 1987;19:3689-3690.
75. Francis G, Sharma B, Collins A, Helseth H, Comty C: Coronary-artery surgery in patients with end-stage renal disease. Ann Intern Med 1980;92:499-503.
76. Rostand S, Kirk K, Rutsky E, Pacifico A: Results of coronary artery bypass grafting in end-stage renal disease. Am J Kid Dis 1988;12:266-270.
77. Ko W, Kreiger K, Isom O: Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg 1993; 55:667-684.
78. Kaul T, Fields B, Reddy M, Kahn D: Cardiac operations in patients with end-stage renal disease. Ann Thorac Surg 1994;57:691-696.
79. Batiuk T, Kurtz S, Oh J, Orszulak T: Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991;66:45-53.
80. Owen C, Cummings R, Sell T, Schwab S, Jones R, Glower D: Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg 1994;58:1729-1733.
81. Peper W, Taylor P, Paganini E, Svensson L, Ghattas M, Loop F: Mortality and results after cardiac surgery in patients with end-stage renal disease. Cleve Clin J Med 1988;55:63-67.
82. Blakeman B, Pifarre R, Sullivan H, Montoya A, Bakhos M: Cardiac surgery for chronic renal dialysis patients. Chest 1989;95:509-511.
83. Laws K, Merrill W, Hammon J, Prager R, Bender H: Cardiac surgery in patients with chronic renal disease. Ann Thorac Surg 1986;42:152-157.
84. Marshall W, Rossi N, Meng R, Wedige-Stecher T: Coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 1986;42[Suppl]:S12-S15.
85. Monson B, Wickstrom P, Haglin J, Francis G, Comty C, Helseth H: Cardiac operation and end-stage renal disease. Ann Thorac Surg 1980;30:267-272.
86. De Meyer M, Wyns W, Dion R, Khoury G, Pirson Y, de Strihou C. Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 1991;36:147-151.
87. Deutsch E, Bernstein R, Addonizio P, Kussmaul W: Coronary artery bypass surgery in patients on chronic hemodialysis. Ann Intern Med 1989;110:369-372.
88. Opsahl J, Husebye D, Helseth H, Collins A: Coronary artery bypass surgery in patients on maintenance dialysis: Long-term survival. Am J Kidney Dis 1988;12:271-274.
89. Landau C, Lange RA, Hillis LD: Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330: 981-993.
90. Reusser L, Osborn L, White H, Sexson R, Crawford M: Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 1994;73: 965-967.
91. Kahn J, Rutherford B, McConahay D, Johnson W, Giorgi L, Hartzler G: Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-489.
92. Rinehart A, Herzog C, Collins A, Flack J, Ma J, Opsahl J: A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995;25:281-290.
93. Ahmed W, Shubrooks S, Gibson C, Baim D, Bittl J: Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994;128:252-255.
94. Fischman D, Leon M, Baim D, et al.: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
95. Surreys P de Jaegere P, Kiemeneij F, et al.: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
96. Manske C, Wang Y, Rector T, Wilson R, White C: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992;340:998-1002.